CASP3 and breast cancer: In striking contrast to the BRCA1/2-proficient SKBR3, MDA-MB231, and JIMT1 breast cancer cells, the dual inhibition of CASP3 + 7 was lethal in SUM149PT cells (Fig 7A–7C).